If more than one topical ophthalmic drug is being used, the drugs should be administered at least ten minutes apart. Do not touch your eye with the dropper tip, as doing so can scratch your eye and contaminate the solution inside the bottle. VIZhyal 0.1% is a sterile, ophthalmic solution that soothes and moisturizes the ocular surface to alleviate symptoms associated with moderate dry eyes, such as burning, irritation and foreign body sensation. VIZhyal 0.1% acts as a humectant on the eye, providing relief of dry eye conditions, including those associated with the use of PC, infrequent blinking, medical treatments, atmospheric pollution, air conditioning, central heating, wind and sun.

In a multiple-dose, double-masked, active treatment (dorzolamide multidose) controlled, two period crossover multiclinic study, in 152 patients with elevated baseline intraocular pressure (baseline IOP ≥22 mmHg) in one or both eyes, dorzolamide preservative-free had an IOP-lowering effect equivalent to that of dorzolamide multidose. The safety profile of dorzolamide preservative-free was similar to dorzolamide multidose. Buffered solution with Calendula extract, Hamamelis extract, EDTA 0.12%, PHMB 0.0001%. Storage instructions Hydroxypropyl guar or combination product containing trehalose can be used for more severe symptoms as they can reduce inflammation and protect ocular surface. irritation including redness, pain, eyelid crusting, transient myopia (which resolved upon discontinuation of therapy), corneal oedema, ocular hypotony, choroidal detachment following filtration surgery Sodium hyaluronate 0.1% - 0.2% PF eye drops. Prescribe most cost effective brand, assess patient’s dexterity for choice. For e.g.:

Find in store

Hold the bottle directly below the cap and turn the cap to open the bottle. Do not touch anything with the tip of the bottle to avoid contamination of the solution. Allergic type reactions such as rash, hives, itching, in rare cases possible swelling of the lips, eyes and mouth, shortness of breath, and more rarely wheezing

Preparations, substances and products for the eyes; eye lotions, eye moisturisers, cosmetic preparations for the eyes. Investigations: dorzolamide was not associated with clinically meaningful electrolyte disturbances. If you develop allergic reactions including hives, swelling of the face, lips, tongue, and/or throat which may cause difficulty in breathing or swallowing, you should stop using this medicine and seek immediate medical advice.The patient should close the eye and press the inner corner of the eye with a finger for about two minutes. This helps to stop the medicine from getting into the rest of the body.

Prescribe generically or use most cost effective brand. For e.g. VIZcellose** 0.5% or VIZcellose** 1% PF eye drops. 10ml, 3m expiry. VIZcellose 1.0% is a sterile, ophthalmic solution that protects and moisturizes the ocular surface of the eye. VIZcellose 1.0% relieves the symptoms of dry eyes such as burning, itching and foreign body sensation. Acting as a lubricant, VIZcellose drops provide relief from dry eye conditions, including those associated with the use of PC, infrequent blinking, certain medical treatments, atmospheric pollution, dry atmospheres (e.g., air conditioning), and ophthalmic stress due to the use of eye lenses. VIZcellose 1.0% can be suggested in the case of mild dry eye syndrome, when immediate protective action and lasting relief is required. Prescribing VIZcellose (carmellose) eye drops by brand could cut over 60% from CCG prescribing costs without compromising patient care. Presentation The VIZHyal 0.2% trademark was assigned an Application Number # UK00003314178 by the UK Intellectual Property Office (UKIPO). Composition: 0.5% carmellose sodium (carboxymethyl cellulose), boric acid, sodium tetraborate decahydrate, sodium chloride, water for injection.

Storage instructions

Do not allow the tip of the multi dose container to touch the eye or areas around the eye It may become contaminated with bacteria that can cause eye infections leading to serious damage of the eye, even loss of vision. Composition: Sodium hyaluronate cross polymer aqueous solution (of which sodium hyaluronate cross polymer 0,4%), Trometamol, Hydrochloric acid 2N, Sodium chloride, water for injection. After all doses have been used there will be some Vizidor left in the bottle. The patient should not be concerned since an extra amount of Vizidor has been added and the patient will get the full amount of Vizidor that their doctor has prescribed. Using the excess medicine remaining in the bottle after the patient has completed the course of treatment should not be attempted.

Efficacy results in paediatric patients suggest that the mean IOP decrease observed in the dorzolamide group was comparable to the mean IOP decrease observed in the timolol group even if a slight numeric advantage was observed for timolol.Composition: Hyaluronic acid sodium salt (high molecular weight), Hyaluronic acid sodium salt (low molecular weight) L-Glycine, Vitamin E, TPGS, Extract of Centella Asiatica (L.) Urban (titrated in asiaticoside 3%), Polyvinylpyrrolidone, D-Mannitol, Sodium phosphate monobasic monohydrate, Sodium Phosphate dibasic dodecahydrate, Sodium Chloride, water for injection. If allergic reactions (e.g. conjunctivitis and eyelid reactions) are observed, treatment discontinuation should be considered. Uses the COMOD system. Patient must press the base of the bottle to release one measured dose. You can also prescribe the ComplEye aid which assists administration of the drops and prevents the tip touching the eye. If a more viscous drop is required, use Clinitas Multi** 0.4% (sodium hyaluronate) PF eye drop. 10ml, approx. 200 drops, 3m expiry. The management of patients with acute angle-closure glaucoma requires therapeutic interventions in addition to ocular hypotensive agents. Dorzolamide has not been studied in patients with acute angle-closure glaucoma.